3. Historical Overview
1950s - 1980s
Early Exploration
1980s - 1990
Nanoparticles in Drug Delivery
1995
FDA Approval of First
Nanopharmaceutical
2000s - 2010
Nanomedicine Expands
2010
Emergence of Personalized Medicine
2010s - Present
Nanodiagnostics and Beyond
4. Why Need of Nanotechnology
Provide sustained release/ control release/ prolonged release of the drug
Decrease dosing frequency Decreased dose
Lesser dose related side effects
Active targeting Passive targeting
Site specific drug delivery (Eg: Cancer)
Improved dissolution Improved release
Improved bioavailability
5. Application of Nanotechnology
The application of nanotechnology in pharmaceutical formulation as Nanosuspension, Nanoemulsion, Nanospheres
and Nano capsules.
Drug delivery
system
Targeted drug
delivery system
Personalized
medicine
Cancer
treatment
Vaccine
development
Diagnostic
Imaging
Drug screening
and discovery
controlled
release
Neurological
drug delivery
Infection control
Gene therapy
Quality Control
and
Characterization
6. Nanoparticles in Drug Delivery
• Encapsulation of Drugs
• Improved Solubility
• Controlled Release
• Targeted Delivery
• Enhanced Bioavailability
Doxil(Liposomal Doxorubicin) Abraxane (Nanoparticle Albumin-
Bound Paclitaxel)
Examples of drugs benefiting from Nanoparticle delivery
Examples of drugs enefiting from nanoparticle delivery
7. Nanotechnology Improved drug formulations
• Nanosized Drug Particles
• Increased Bioavailability
• Improved Solubility
• Enhanced Drug Dissolution
Nanotechnology enhance drug formulations
• Improved Therapeutic Efficacy
• Reduced Side Effects
• Patient Convenience
• Expanded Therapeutic Options
Adavantages
8. Targeted Drug Delivery
• Nanoparticle Engineering
• Selective Accumulation
• Cellular Uptake
• Controlled Drug Release
• Higher Drug Concentration at the Target Site
• Lower Doses Required
• Minimized Systemic Side Effects
• Enhanced Treatment Efficacy
• Improved Patient Quality of Life
Benefits of targeted drug delivery
Targeted drug delivery is a revolutionary approach that harnesses nanotechnology to precisely deliver medications to specific cells or tissues
within the body. This strategy minimizes the exposure of healthy tissues to the drug, reducing systemic side effects.
9. Personalized Medicine
How nanotechnology is enabling personalized
medicine
• Molecular Diagnostics
• Drug Delivery Customization
• Biomarker Identification
• Therapeutic Tailoring
Case Studies or Examples
• Nanoparticle-Based Cancer Therapy
• Nanotechnology in Oncology
• Gene Editing and CRISPR-Cas9
• Personalized Drug Dosage
10. Diagnostic Application
Diagnostic techniques
• Nano sensors
• Nano particles
• Nano devices
Diagnostic tools and advancements
• Nanoscale Biosensors
• Nanoparticle-Based Imaging Agents
• Lab-on-a-Chip Devices
• Nanopore Sequencing
• Nanoparticle-Based Drug Delivery and Imaging for
Theranostics
11. Regulatory Challenges
• Nanomaterial
Characterization
• Toxicological Assessments
• Regulatory Gaps
• Batch-to-Batch Variability:
• Manufacturing Standards
• Long-Term Effects
Mention agencies overseeing nanotechnology in
pharmaceuticals
Discuss regulatory hurdles and safety
concerns
• U.S. Food and Drug Administration
(FDA)
• European Medicines Agency (EMA)
• World Health Organization (WHO)
• National Regulatory Agencies
12. Future Trends
Personalized Nanomedicine
Smart Nanoparticles
RNA-Based Nanotherapeutics
Immunotherapeutic Nanoparticles
Nanoparticle Vaccines
Advanced Targeting Strategies
Personalized Cancer Therapies
Gene Editing with Nanoparticles
Drug-Device Combinations
Global Access to Nanomedicines
Emerging trends and technologies in
Nanopharmaceuticals
Predictions for the future of
nanotechnology in the pharmaceutical
industry
13. Real Case Studies
Case Study 1: Lipid Nanoparticles and COVID-19 Vaccines
Background:During the COVID-19 pandemic, the rapid development of effective vaccines was critical.
Nanotechnology played a pivotal role in the success of several COVID-19 vaccines.
Example:Pfizer-BioNTech and Moderna COVID-19 vaccines utilize lipid nanoparticles to deliver
messenger RNA (mRNA) encoding the spike protein of the virus. These lipid nanoparticles protect the
fragile mRNA and facilitate its entry into human cells.
Impact:Thesenanopharmaceuticalsachieved exceptional efficacy rates and have been instrumental in
controlling the spread of the virus worldwide
Case Study 2: Doxil (Liposomal Doxorubicin)
Background:Doxil, a liposomal formulation of the chemotherapy drug doxorubicin, was one of the
earliest successful applications of nanotechnology in pharmaceuticals.
Example:Doxilencapsulates doxorubicin within liposomes, improving its safety profile by reducing
cardiotoxicity. This allowed for higher doses of doxorubicin to be administered.
Impact:Doxilbecame a standard treatment for various cancers, including ovarian cancer and
Kaposi's sarcoma, offering improved efficacy and fewer side effects compared to
conventional doxorubicin.
Case Study 3: Abraxane (Nanoparticle Albumin-Bound Paclitaxel)
Background:Paclitaxel, used in cancer treatment, had solubility and formulation
challenges. Abraxane addressed these issues.
Example:Abraxane employs nanoparticle albumin-bound paclitaxel to enhance
drug solubility and delivery. It binds paclitaxel to albumin nanoparticles.
Impact:Abraxane is now a vital component of breast, lung, and pancreatic
cancer therapies, offering improved response rates and reduced side effects.
Case Study 4: Iron Oxide Nanoparticles in MRI Imaging
Background:Magnetic resonance imaging (MRI) is a crucial diagnostic tool.
Nanotechnology has improved MRI contrast agents.
Example:Iron oxide nanoparticles have been developed as contrast agents for MRI. They
provide superior imaging capabilities, allowing for the detection of smaller lesions and
tumors.
Impact:Iron oxide nanoparticles have enhanced the accuracy of disease diagnosis and
treatment planning in areas like oncology and neurology.
14. Challenges And Ethical Considerations
• Safety and Long-Term Effects
• Equity and Access
• Transparency and Informed
Consent
• Regulatory Oversight
Challenges in Scaling up Nanopharmaceutical
Production
Ethical and Societal Concerns related to
Nanotechnology
• Consistency and Quality Control
• Cost-Effective Production
• Regulatory Compliance
• Supply Chain Complexity
• Environmental Impact
15. Collaboration and Research
• Interdisciplinary Cooperation
• Accelerated Innovation
• Safety and Efficacy Assurance
Ongoing Research Areas and Potential
Collaborations
The Importance of
Collaboration
• Nanoparticle-Based Targeted Drug
Delivery
• Nanomedicine for Rare Diseases
• Nanoformulations for Vaccines
• Environmental Impact Assessment
• Nanotoxicology Studies
16. Other Emerging Techniques
• Artificial intelligence
• Big data and analytics
• Flexible production
• Precision medicine
• Additive manufacturing
• Block chain
• Extended reality
• Real world data
• Digital therapeutics
• Curative therapies
17. Conclusion
Nanotechnology represents a paradigm shift in the pharmaceutical industry, offering unprecedented
opportunities to improve patient care and drive medical innovation. It enables safer, more effective
treatments, enhances diagnostics, and paves the way for personalized medicine. As we navigate
challenges and ethical considerations, collaboration and research will continue to propel
nanotechnology forward, ultimately shaping the future of healthcare. Nanotechnology and other
techniques in pharma industry are not just an evolution; it's a revolution, and its impact on
pharmaceuticals is profound and enduring.